Curtis Jackson was living the life of his dreams – a loving and supportive wife, three wonderful children, and a future that looked as bright as it could be. Then, one day, without warning, the dream was shattered.
At the age of 46, Curtis Jackson was diagnosed with cholangiocarcinoma, one of the most aggressive and deadly cancers affecting the liver. The disease is often referred to as a ‘silent killer’, as it rarely produces symptoms until it is already well advanced.
By then, there are few treatment options and the prognosis is very poor. Curtis already had a chronic liver disease, primary sclerosing cholangitis (PSC), which causes inflammation and scarring of the bile ducts.
PSC increases the risk of liver cancer and made Curtis undergo regular checkups at the Mayo Clinic. Thanks to these screenings, his cholangiocarcinoma was detected early, likely saving his life.
According to the Mayo Clinic experts, early detection is crucial to improve the chances of survival. If the cancer becomes too advanced, neither surgery nor transplantation is possible, and the disease is considered incurable.
The treatment that gave Curtis a chance was an unusual approach: liver transplantation. Very few centers in the world offer transplants for patients with cholangiocarcinoma, but the Mayo Clinic is one of the exceptions for carefully selected cases. In Curtis’ case, doctors decided that a liver transplant was his best chance, allowing him to undergo a treatment rarely available for this type of cancer.
Curtis’ story is an example of how early detection, specialized care and access to advanced treatments can transform the prognosis of an otherwise almost always fatal disease.
